Skip to main content Homepage

HLO News Details


Seeking Applicants for Direct Entry Midwifery Continuing Education Committee

Wednesday, May 5, 2021

​On April 15, 2021, the Board of Direct Entry Midwives (Board) tasked the Health Licensing Office (HLO) with assembling an Education Committee (EC) to review the Legend Drugs and Devices Initial Continuing Education Program (LDDICEP) to determine which requirements must be completed to obtain licensure in Oregon. The EC will be tasked with reviewing: 

  • Education completed at in-state and out-of-state schools;
  • Other state licensure, including previous experience;
  • Methods to verify education and experience; and
  • Additional educational requirements, including supervisory requirements. 

All recommendations will be presented to the Board for final approval and implementation. 

The Board determined the EC will include seven members to include the following representation: 

Five Active or Retired Direct Entry Midwives:

  • Three – Licensed Direct Entry Midwives.
  • One – Licensed Direct Entry Midwife with general education experience.
  • One – Licensed Direct Entry Midwife with experience directly teaching Legend Drugs and Devices.

 One – Certified Nurse Midwife with community birth experience.

One –This member includes, but is not limited to, one of the following license holders who has direct clinical education experience:

  • ​Registered Nurse with obstetrics experience.
  • Paramedic. 

All EC members must be in good-standing with no current or pending disciplinary action. In addition, unlicensed or traditional midwives will not be considered for membership. 

Below are the proposed dates for the EC meetings; the dates of the meetings and the number of meetings scheduled are subject to change to accommodate the members appointed to the EC, and to allow the EC the appropriate amount of time to review and make any recommended revisions to the LDDICEP. 

Date: Action: Time:
July 15, 2021Legend Drugs & Devices Committee10 a.m.
August 26, 2021Legend Drugs & Devices Committee10 a.m.
September 23, 2021Legend Drugs & Devices Committee10 a.m.

​Based on the proposed schedule, any recommended revisions to the LDDICEP will be presented to the Board on Thursday, October 21, 2021. 

To limit the exposure and spread of the COVID-19 virus and adhere to the Governor's physical distancing measures, the HLO is prohibiting in-person attendance at meetings. All EC meetings will be held using Microsoft Teams and directions on how to access the meetings will be provided to the appointed EC members prior to the first scheduled meeting. 

If you meet one of the aforementioned representation criteria and are interested in serving as an EC member, please complete and return the interest application by June 5, 2021, (4 p.m.), by email to, or by postal mail to: 

A​ttn: Cerynthia Murphy

Health Licensing Office

1430 Tandem Ave., Suite 180

Salem, Oregon 97301-2192

​For questions or additional information, please email, or call (503) 373-1816.


Your browser is out-of-date! It has known security flaws and may not display all features of this and other websites. Learn how